A collaboration among interventional oncologists pooling outcomes of 155 patients with neuroendocrine tumor liver metastases treated at seven cancer centers across the United States has won the CVIR Award for most highly cited article at the 2018 CIRSE Annual Meeting in Lisbon, Portugal.
Controversy erupted at the HCC Evidence-based Practice Debates at WCIO 2016 regarding combination therapy for HCC. Panelist, expert and author Karen Brown, MD from Memorial Sloan-Kettering Cancer Center responds:
It was an exciting day at the Suzhou International Expo Center, where the 12th Asia-Pacific Congress of Cardiovascular & interventional Radiology (APCCVIR 2016) hosted joint sessions with SIR, CIRSE and WCIO.
As part of FDA’s work to prevent and mitigate drug shortages, the Agency created the FDA Drug Shortage Assistance Award to provide public recognition to drug companies and manufacturers who have demonstrated a commitment to preventing or alleviating drug shortages of medically necessary drugs.
Billboards and busses in Philadelphia abound with Blue Cross’ current Live Fearless campaign, most featuring healthy-looking young people engaged in vigorous activities. “Live in Fear” would be a better tagline for Blue Cross patients with liver metastases, as two of my recent patients discovered...